Mechanisms of Drug Release in Nanotherapeutic Delivery Systems
The DOI matches its Crossref record; 493 of the 493 references it cites were found in a registry or an index.
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTMechanisms of Drug Release in Nanotherapeutic Delivery SystemsPamela T. Wong and Seok Ki Choi*View Author Information Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, United States*E-mail: [email protected]. Tel.: (734) 647-0052. Fax: (734) 936-2990.Cite this: Chem. Rev. 2015, 115, 9, 3388–3432Publication Date (Web):April 27, 2015Publication History Received22 August 2014Published online27 April 2015Published inissue 13 May 2015https://pubs.acs.org/doi/10.1021/cr5004634https://doi.org/10.1021/cr5004634review-articleACS PublicationsCopyright © 2015 American Chemical SocietyRequest reuse permissionsArticle Views14486Altmetric-Citations396LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Antineoplastic agents,Drug release,Molecules,Organic compounds,Peptides and proteins Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some authors evaluated the encapsulation efficiency of volatile hydrophilic compounds by Gas Chromatography, since, as a result of drug-polymeric micelle interactions, a decrease of the amount of free volatile compounds in bulk water was found [114].”
From Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions (2021) · cites this paper as [114]
Citations
Cites
1 retracted
Gui, R., Wan, A., Liu, X.-F., & Jin, H. (2014) · Chemical Communications · doi:10.1039/c3cc47981a · Cited by 52
RetractedDaniel, M.-C., & Astruc, D. (2004) · Chemical Reviews · doi:10.1021/cr030698+ · Cited by 12,446
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Tasis, D., Tagmatarchis, N., Bianco, A., & Prato, M. (2006) · Chemical Reviews · doi:10.1021/cr050569o · Cited by 4,273
Mammen, M., Choi, S.-K., & Whitesides, G. M. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981102)37:20<2754::aid-anie2754>3.0.co;2-3 · Cited by 4,110
Self-citation
Research works printed but not linked: 47
- Majoros I. J., 2009, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 1, 502
- Fischer M., 1999, Angew. Chem., Int. Ed., 38, 884, 10.1002/(sici)1521-3773(19990401)38:7<884::aid-anie884>3.0.co;2-k · DOI · Paper page
- Maeda H., 1989, Crit. Rev. Ther. Drug Carrier Syst., 6, 193
- Raha S., 2010, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 3, 269
- Bhaskar V., 2003, Cancer Res., 63, 6387
- Hong S., 2007, Chem. Biol. (Oxford, U. K.), 14, 107
- Choi Y., 2005, Chem. Biol. (Oxford, U. K.), 12, 35
- Yellepeddi V. K., 2009, Anticancer Res., 29, 2933
- Maturo J., 1988, Biochem. Pharmacol. (Amsterdam, Neth.), 37, 3755
- de Groot F. M. H., 2002, Mol. Cancer Ther., 1, 901
- Bosnjakovic A., 2011, Nanomedicine (N. Y., NY, U. S.), 7, 284
- Levy G. A., 2006, Hepatology (Hoboken, NJ, U. S.), 43, 581
- Mahajan S. D., 2012, Methods in Enzymology, 509
- Salvi A., 1997, Drug Metab. Dispos., 25, 395
- Sanghani S. P., 2003, Clin. Cancer Res., 9, 4983
- Yoon K. J. P., 2003, Mol. Cancer Ther., 2, 1171
- Tougou K., 1998, Drug Metab. Dispos., 26, 355
- Barnes K. R., 2004, Chem. Biol. (Oxford, U. K.), 11, 557
- DeFeo-Jones D., 2000, Nat. Med. (N. Y., NY, U. S.), 6, 1248
- Wong B. K., 2001, Drug Metab. Dispos., 29, 313
- Hervio L. S., 2000, Chem. Biol. (Oxford, U. K.), 7, 443
- Silver D. A., 1997, Clin. Cancer Res., 3, 81
- Felsen C. N., 2014, Am. J. Physiol.: Lung Cell. Mol. Physiol., 306, L764
- Butler P. J., 1967, Biochem. J., 103, 78b
- Schmalfeldt B., 2001, Clin. Cancer Res., 7, 2396
- Incorvaia L., 2007, Anticancer Res., 27, 1519
- Trail P. A., 1992, Cancer Res., 52, 5693
- Hinman L. M., 1993, Cancer Res., 53, 3336
- Mahmud N. P., 1998, Anti-Cancer Drug Des., 13, 655
- Hunter F. W., 2012, Biochem. Pharmacol. (Amsterdam, Neth.), 83, 574
- van Haaften R. I. M., 2001, Biochem. Pharmacol. (Amsterdam, Neth.), 61, 715
- Rodrigues M. L., 1995, Cancer Res., 55, 63
- Rodrigues M. L., 1995, Chem. Biol. (Oxford, U. K.), 2, 223
- Goard M., 2005, Chem. Biol. (Oxford, U. K.), 12, 685
- Chourasia M. K., 2003, J. Pharm. Pharm. Sci., 6, 33
- Berchane N. S., 2007, Int. J. Pharm. (Amsterdam, Neth.), 337, 118
- Zhang M., 2011, Int. J. Nanomed., 6, 2337
- Kommareddy S., 2007, Nanomedicine (N. Y., NY, U. S.), 3, 32
- Mitran R.-A., 2014, Cent. Eur. J. Chem., 12, 1
- Wu C., 2011, Int. J. Pharm. (Amsterdam, Neth.), 403, 162
- Nelson J. L., 2002, Cancer Res., 62, 7280
- Li C., 1998, Cancer Res., 58, 2404
- Seymour L. W., 2002, J. Clin. Oncol., 20, 1668, 10.1200/jco.2002.20.6.1668 · doi:10.1200/jco.2002.20.6.1668 · Paper page
- Vasey P. A., 1999, Clin. Cancer Res., 5, 83
- Yokoyama M., 1991, Cancer Res., 51, 3229
- Wosikowski K., 2003, Clin. Cancer Res., 9, 1917
- Yurkovetskiy A., 2010, Cancer Res., 70
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Ghezzi, M., Pescina, S., Padula, C., Santi, P., Del Favero, E., Cantù, L., & Nicoli, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.031 · Cited by 1,135
Moradi Kashkooli, F., Soltani, M., & Souri, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.012 · Cited by 514
PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy
Abedi-Gaballu, F., Dehghan, G., Ghaffari, M., Yekta, R., Abbaspour-Ravasjani, S., Baradaran, B., Ezzati Nazhad Dolatabadi, J., & Hamblin, M. R. (2018) · Applied Materials Today · doi:10.1016/j.apmt.2018.05.002 · Cited by 487
“However, the pH dependent cleavage of amide linkers including cis-aconityl, citraconyl and maleyl groups has been explored in controlled drug release [61].”
BackgroundTumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Peng, S., Xiao, F., Chen, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202103836 · Cited by 441
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
Chen, B., Dai, W., He, B., Zhang, H., Wang, X., Wang, Y., & Zhang, Q. (2017) · Theranostics · doi:10.7150/thno.16684 · Cited by 342
“The main linkers in the design of drug-polymer conjugate in response to hypoxia include indolequinone, benzoquinone, nitroaromatics and N-oxide [144].”
BackgroundSultana, A., Zare, M., Thomas, V., Kumar, T. S. S., & Ramakrishna, S. (2022) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2022.100134 · Cited by 315
Remote Light‐Responsive Nanocarriers for Controlled Drug Delivery: Advances and Perspectives
Zhao, W., Zhao, Y., Wang, Q., Liu, T., Sun, J., & Zhang, R. (2019) · Small · doi:10.1002/smll.201903060 · Cited by 329
Evolution of macromolecular complexity in drug delivery systems
Kakkar, A., Traverso, G., Farokhzad, O. C., Weissleder, R., & Langer, R. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0063 · Cited by 320
Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics
Lee, M. H., Sharma, A., Chang, M. J., Lee, J., Son, S., Sessler, J. L., Kang, C., & Kim, J. S. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00557a · Cited by 317
Cheng, H., Zhang, S., Qi, J., Liang, X., & Yoon, J. (2021) · Advanced Materials · doi:10.1002/adma.202007290 · Cited by 276
Design Considerations for Hydrogel Wound Dressings: Strategic and Molecular Advances
Op 't Veld, R. C., Walboomers, X. F., Jansen, J. A., & Wagener, F. A. D. T. G. (2020) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2019.0281 · Cited by 276
“189,197,198 In a diffusion-based system based on placing the drug in central reservoirs, the drug must exit its container by diffusion through the surrounding polymer, a step that can be rate limited and will give more control over the release rate.”
Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review
Kumari, R., Sunil, D., & Ningthoujam, R. S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.041 · Cited by 263
A review of drug release mechanisms from nanocarrier systems
Ding, C., & Li, Z. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.03.130 · Cited by 268
Stimuli-Responsive Drug-Delivery Systems Based on Supramolecular Nanovalves
Li, Z., Song, N., & Yang, Y.-W. (2019) · Matter · doi:10.1016/j.matt.2019.05.019 · Cited by 256
“Combined with the sophisticated gating nanotechnology, a rational drug-delivery process could be divided into three parts: (1) loading drug molecules into the channels of nanocarriers, whose surface has been modified with stalks for interacting with gated bulky materials; (2) installing nanovalves to close pore orific…”
BackgroundDisulfide-Based Multifunctional Conjugates for Targeted Theranostic Drug Delivery
Lee, M. H., Sessler, J. L., & Kim, J. S. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00406 · Cited by 254
Nanocarriers and Their Loading Strategies
Wang, N., Cheng, X., Li, N., Wang, H., & Chen, H. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801002 · Cited by 245
Recent advances in biomedical applications of fluorescent gold nanoclusters
Zheng, Y., Lai, L., Liu, W., Jiang, H., & Wang, X. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.02.005 · Cited by 241
“In general, drugs can be released from AuNCs delivery system via the thiol/disulfide exchange [164].”
BackgroundCheng, Y., Dai, J., Sun, C., Liu, R., Zhai, T., Lou, X., & Xia, F. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712803 · Cited by 241
Farooq, M. U., Novosad, V., Rozhkova, E. A., Wali, H., Ali, A., Fateh, A. A., Neogi, P. B., Neogi, A., & Wang, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-21331-y · Cited by 228
“Hence targeting with BLM capped AuNPs (S4) have shown increase in cytotoxicity as compared to S1, S2 and S3 products (Fig.”
BackgroundInfluentialRetractedStimuli-responsive dendrimers in drug delivery
Wang, H., Huang, Q., Chang, H., Xiao, J., & Cheng, Y. (2016) · Biomaterials Science · doi:10.1039/c5bm00532a · Cited by 215
Light-Responsive Nanoparticles for Highly Efficient Cytoplasmic Delivery of Anticancer Agents
Wang, Y., Deng, Y., Luo, H., Zhu, A., Ke, H., Yang, H., & Chen, H. (2017) · ACS Nano · doi:10.1021/acsnano.7b05214 · Cited by 217
Trzeciak, K., Chotera-Ouda, A., Bak-Sypien, I. I., & Potrzebowski, M. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070950 · Cited by 196
“This release mechanism is often called linker cleavage and has been summarized in several excellent reviews [109,110].”
BackgroundHaripriyaa, M., & Suthindhiran, K. (2023) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00569-y · Cited by 175
“Controlled drug release occurs through a cleavage of ester hydrolysis, amide hydrolysis, hydrazone hydrolysis, disulfide exchange, mannich bases and thermolysis [94].”
BackgroundThe chemistry of heterocycles in the 21st century
Charushin, V. N., Verbitskiy, E. V., Chupakhin, O. N., Vorobyeva, D. V., Gribanov, P. S., Osipov, S. N., Ivanov, A. V., Martynovskaya, S. V., Sagitova, E. F., Dyachenko, V. D., et al. (2024) · Russian Chemical Reviews · doi:10.59761/rcr5125 · Cited by 182
Glutathione-mediated nanomedicines for cancer diagnosis and therapy
Ding, Y., Dai, Y., Wu, M., & Li, L. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.128880 · Cited by 185
Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review
Indoria, S., Singh, V., & Hsieh, M.-F. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119314 · Cited by 168
Bifunctional antimicrobial conjugates and hybrid antimicrobials
Klahn, P., & Brönstrup, M. (2017) · Natural Product Reports · doi:10.1039/c7np00006e · Cited by 181
Kim, K., Lee, S., Jin, E., Palanikumar, L., Lee, J. H., Kim, J. C., Nam, J. S., Jana, B., Kwon, T.-H., Kwak, S. K., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05736 · Cited by 181
Sun, Y., & Davis, E. (2021) · Nanomaterials · doi:10.3390/nano11030746 · Cited by 165
Stimulus-cleavable chemistry in the field of controlled drug delivery
Xue, Y., Bai, H., Peng, B., Fang, B., Baell, J., Li, L., Huang, W., & Voelcker, N. H. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01061h · Cited by 173
Drug-loaded polymeric nanoparticles: a review
Castro, K. C. D., Costa, J. M., & Campos, M. G. N. (2022) · International Journal of Polymeric Materials and Polymeric Biomaterials · doi:10.1080/00914037.2020.1798436 · Cited by 161
Nanoparticles incorporated hydrogels for delivery of antimicrobial agents: developments and trends
Ahmad, N., Bukhari, S. N. A., Hussain, M. A., Ejaz, H., Munir, M. U., & Amjad, M. W. (2024) · RSC Advances · doi:10.1039/d4ra00631c · Cited by 167
Polymer encapsulation of ruthenium complexes for biological and medicinal applications
Villemin, E., Ong, Y. C., Thomas, C. M., & Gasser, G. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0088-0 · Cited by 167
Nanocarriers based novel and effective drug delivery system
Khizar, S., Alrushaid, N., Alam Khan, F., Zine, N., Jaffrezic-Renault, N., Errachid, A., & Elaissari, A. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122570 · Cited by 171
Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy
Chang, D., Ma, Y., Xu, X., Xie, J., & Ju, S. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.707319 · Cited by 161
Leveraging Physiology for Precision Drug Delivery
Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017) · Physiological Reviews · doi:10.1152/physrev.00015.2016 · Cited by 169
“When degradation or dissociation of the nanocarrier is needed to release the encapsulated drug, methods to maintain the drug in the carrier during circulation but release it after arriving at its destination become important for efficient drug delivery (468).”
MethodAdvancement in integrin facilitated drug delivery
Arosio, D., & Casagrande, C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.001 · Cited by 161
Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases
Dheer, D., Nicolas, J., & Shankar, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.010 · Cited by 144
“6 Whereas several reviews have already been published on targeted polymer-based drug delivery systems [28-31], cysteine Cathepsins as imaging probes [32-35], ageing and neurodegeneration [36], disease management [37] and other protease functions [38, 39], the dynamic involvement of Cathepsins in targeted drug delivery…”
BackgroundTan, Y., Zhu, Y., Zhao, Y., Wen, L., Meng, T., Liu, X., Yang, X., Dai, S., Yuan, H., & Hu, F. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.036 · Cited by 143
“Importantly, the controlled drug release inside the mitochondria is still much needed [12, 13].”
BackgroundDong, K., Wang, Z., Zhang, Y., Ren, J., & Qu, X. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b11972 · Cited by 125
Recent advances in nanotherapeutic strategies for spinal cord injury repair
Song, Y. H., Agrawal, N. K., Griffin, J. M., & Schmidt, C. E. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.011 · Cited by 130
Lactoferrin functionalized PEG-PLGA nanoparticles of shikonin for brain targeting therapy of glioma
Li, H., Tong, Y., Bai, L., Ye, L., Zhong, L., Duan, X., & Zhu, Y. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.08.155 · Cited by 125
RETRACTED: An Overview of Polymeric Nanoparticles-Based Drug Delivery System in Cancer Treatment
Dristant, U., Mukherjee, K., Saha, S., & Maity, D. (2023) · Technology in Cancer Research & Treatment · doi:10.1177/15330338231152083 · Cited by 121
“Additionally, many studies and reviews have been found in the research area, focusing on the rational design of different molecules and showing their importance in drug release mechanisms.(106) Additionally, natural items can stimulate the creation of new drugs with desired physicochemical features and offer intriguin…”
BackgroundRetractedCell membrane-coated nanomaterials for cancer therapy
Zeng, S., Tang, Q., Xiao, M., Tong, X., Yang, T., Yin, D., Lei, L., & Li, S. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100633 · Cited by 128
“For example, functionalized NPs can control drug release through different internal and external stimuli (such as pH, glutathione, light, and ultrasound), which may help prevent premature drug leakage in healthy tissues [36].”
BackgroundInnovative Linker Strategies for Tumor‐Targeted Drug Conjugates
Corso, A. D., Pignataro, L., Belvisi, L., & Gennari, C. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201903127 · Cited by 125
Haider, M. A., Zaki, K. Z., Hamshary, M. R. E., Hussain, Z., Orive, G., & Ibrahim, H. O. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.11.008 · Cited by 112
“The ultra-small size of the NPs and high drug loading and encapsulation efficiency allow them for extended circulation time and reduced clearance rates from the excretory organs [28,31,32].”
BackgroundA perspective on magnetic core–shell carriers for responsive and targeted drug delivery systems
Albinali, K. E., Zagho, M. M., Deng, Y., & Elzatahry, A. A. F. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s193981 · Cited by 108
“There are many types of nanocarriers such as polymers, micelles, liposomes,(39) dendrimers, gold,(51) carbon nanotubes, silicon, and iron oxide.(57) They have been developed and employed as carriers for drugs or vehicles for the controlled release of drugs, especially for anticancer medicines.”
BackgroundSelf-Assembled DNA Nanocentipede as Multivalent Drug Carrier for Targeted Delivery
Li, W., Yang, X., He, L., Wang, K., Wang, Q., Huang, J. L., Liu, J., Wu, B., & Xu, C. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b08210 · Cited by 107
Sharma, A. K., Kim, E. J., Shi, H., Lee, J. Y., Chung, B. G., & Kim, J. S. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.019 · Cited by 107
Overcoming Drug Resistance by Targeting Cancer Bioenergetics with an Activatable Prodrug
Sharma, A. K., Lee, M. G., Shi, H., Won, M., Arambula, J. F., Sessler, J. L., Lee, J. Y., Chi, S., & Kim, J. S. (2018) · Chem · doi:10.1016/j.chempr.2018.08.002 · Cited by 106
AIE based GSH activatable photosensitizer for imaging-guided photodynamic therapy
Zhang, Y.-H., Li, X., Li, H., Kim, H. S., An, J., Lan, M., Cao, Q., & Kim, J. S. (2020) · Chemical Communications · doi:10.1039/d0cc02045a · Cited by 103
Drug delivery using gold nanoparticles
Dykman, L. A., Khlebtsov, B. N., & Khlebtsov, N. G. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115481 · Cited by 113
Mechanisms of light‐induced liposome permeabilization
Miranda, D., & Lovell, J. F. (2016) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10032 · Cited by 101
Polymer-Functionalized Upconversion Nanoparticles for Light/Imaging-Guided Drug Delivery
Zhang, L., Jin, D., & Stenzel, M. H. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00669 · Cited by 100
Chen, Y., Yang, C., Mao, J., Li, H., Ding, J., & Zhou, W. (2019) · RSC Advances · doi:10.1039/c9ra00834a · Cited by 97
Multifunctional silica nanoparticles as a promising theranostic platform for biomedical applications
Xu, Z., Ma, X., Gao, Y.-E., Hou, M., Xue, P., Li, C. M., & Kang, Y. (2017) · Materials Chemistry Frontiers · doi:10.1039/c7qm00153c · Cited by 96
A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine
Feng, J., Lepêtre‐Mouelhi, S., Gautier, A., Mura, S., Cailleau, C., Coudoré, F., Hamon, M., & Couvreur, P. (2019) · Science Advances · doi:10.1126/sciadv.aau5148 · Cited by 98
“The absence of release of LENK from LENK-SQ-Am was expected given that, in general, an amide bond is chemically and enzymatically more stable than an ester bond (31, 32).”
BackgroundSwitchable Lipids: Conformational Change for Fast pH‐Triggered Cytoplasmic Delivery
Viricel, W., Mbarek, A., & Chain, J. L. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201504661 · Cited by 95
Cheng, Y., Huang, F., Min, X., Gao, P., Zhang, T., Li, X., Liu, B., Hong, Y., Lou, X., & Xia, F. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b02833 · Cited by 94
Upconversion Nanoparticles for Bioimaging and Regenerative Medicine
González‐Béjar, M., Francés‐Soriano, L., & Pérez‐Prieto, J. (2016) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2016.00047 · Cited by 95
“The nanoplatform has to be stable enough to promote controlled release of cargo exclusively when triggering (Loomis et al., 2011; Wong and Choi, 2015).”
BackgroundBai, S., Yang, L., Wang, Y., Zhang, T., Fu, L., Yang, S., Wan, S., Wang, S., Jia, D., Li, B., et al. (2020) · Small · doi:10.1002/smll.202000214 · Cited by 96
Wang, Z., Tang, X., Wang, X., Yang, D., Yang, C., Lou, Y., Chen, J., & He, N. (2016) · Chemical Communications · doi:10.1039/c6cc06616j · Cited by 92
Fatima, R., Katiyar, P., & Kalpana, K. (2025) · Frontiers in Nanotechnology · doi:10.3389/fnano.2025.1564188 · Cited by 107
“The following drug release from these systems occurs by hydrolysis, enzymatic degradation, exchange processes, or redox reactions (Wong and Choi, 2015).”
Feng, Y., Chen, Q., Yin, Q., Pan, G., Tu, Z., & Liu, L. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00608 · Cited by 89
Chen, G., Feng, H. X., Jiang, X., Xu, J. J., Pan, S., & Qian, Z. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b02976 · Cited by 88
Rastegari, B., Karbalaei‐Heidari, H. R., Zeinali, S., & Sheardown, H. D. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.07.044 · Cited by 87
Reduction‐Triggered Transformation of Disulfide‐Containing Micelles at Chemically Tunable Rates
Deng, Z., Yuan, S., Xu, R. X., Liang, H., & Liu, S. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201802909 · Cited by 85
Perspective on Nanoparticle Technology for Biomedical Use
Raliya, R., Chadha, T. S., Haddad, K., & Biswas, P. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160307151409 · Cited by 85
A novel chitosan-based nanomedicine for multi-drug resistant breast cancer therapy
Niu, S., Williams, G. R., Wu, J., Wu, J., Zhang, X., Zheng, H. Y., Li, S.-D., & Zhu, L. (2019) · Chemical Engineering Journal · doi:10.1016/j.cej.2019.02.201 · Cited by 84
“An acidic milieu can accelerate the release of OA by promoting the hydrolysis of the ester bond connecting OA to CS [38], in”
BackgroundYu, Y., Yang, T., & Sun, T. (2020) · Nanomedicine · doi:10.2217/nnm-2019-0395 · Cited by 84
Recent Progress in the Development of Multifunctional Nanoplatform for Precise Tumor Phototherapy
Liu, J., Shi, J., Nie, W., Wang, S., Liu, G., & Cai, K. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001207 · Cited by 84
Li, X., Bottini, M., Zhang, L., Zhang, S., Chen, J., Zhang, T., Liu, L., Rosato, N., Ma, X., Shi, X., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b05136 · Cited by 83
Melnyk, T., Đorđević, S., Conejos‐Sánchez, I., & Vicent, M. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.10.007 · Cited by 86
Aminopeptidase‐N‐activated Theranostic Prodrug for NIR Tracking of Local Tumor Chemotherapy
Xiao, M., Sun, W. C., Fan, J., Cao, J., Li, Y., Shao, K., Li, M., Li, X., Kang, Y., Zhang, W., et al. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201805128 · Cited by 81
Clinical developments of antitumor polymer therapeutics
Parveen, S., Arjmand, F., & Tabassum, S. (2019) · RSC Advances · doi:10.1039/c9ra04358f · Cited by 84
Engineering of carbon nano-onion bioconjugates for biomedical applications
Mamidi, N., Delgadillo, R. M. V., & González-Ortiz, A. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111698 · Cited by 80
Vasić, K., Knez, Ž., & Leitgeb, M. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15080227 · Cited by 76
“Tremendous progress was made in the field of biomedical applications for MNPs with in vivo toxicity and their bioprocesses, while targeting the desired location with drug-J”
BackgroundSelf‐Assembled Nanomedicines for Anticancer and Antibacterial Applications
Zhou, L., Qiu, T. A., Lv, F., Liu, L., Ying, J., & Wang, S. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800670 · Cited by 80
Zhu, Q., Saeed, M., Song, R., Sun, T., Jiang, C., & Yu, H. (2019) · Chinese Chemical Letters · doi:10.1016/j.cclet.2019.12.002 · Cited by 79
Magnetic Nanoparticles for Nanomedicine
Hepel, M. (2020) · Magnetochemistry · doi:10.3390/magnetochemistry6010003 · Cited by 81
Chemical Approaches to Synthetic Drug Delivery Systems for Systemic Applications
Braatz, D., Cherri, M., Tully, M., Dimde, M., Ma, G., Mohammadifar, E., Reisbeck, F., Ahmadi, V., Schirner, M., & Haag, R. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202203942 · Cited by 78
Emam, H. E., & Abdelhameed, R. M. (2017) · Journal of Porous Materials · doi:10.1007/s10934-016-0357-y · Cited by 78
Bhattacharyya, K., & Mukherjee, S. (2017) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20170377 · Cited by 77
Zhang, X., Tan, B. H., & Li, Z. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.11.008 · Cited by 78
Application of Multifunctional Nanomaterials in Radioprotection of Healthy Tissues
Xie, J., Wang, C., Zhao, F., Gu, Z., & Zhao, Y. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800421 · Cited by 77
Gonçalves, M., Mignani, S. M., Rodrigues, J., & Tomás, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.11.016 · Cited by 79
Andoy, N. M., Jeon, K., Kreis, C. T., & Sullan, R. M. A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004503 · Cited by 76
Constantino, V. R. L., Figueiredo, M. P., Magri, V. R., Eulálio, D., Cunha, V. R. R., Alcântara, A. C. S., & Perotti, G. F. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020413 · Cited by 76
Lim, W. Q., Yang, G., Phua, S. Z. F., Chen, H., & Zhao, Y. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b04557 · Cited by 75
Dynamic Softening or Stiffening a Supramolecular Hydrogel by Ultraviolet or Near-Infrared Light
Zheng, Z., Hu, J., Wang, H., Huang, J., Yu, Y., Zhang, Q., & Cheng, Y. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b07204 · Cited by 75
Moorcroft, S. C. T., Jayne, D. G., Evans, S. D., & Ong, Z. Y. (2018) · Macromolecular Bioscience · doi:10.1002/mabi.201800207 · Cited by 74
Bao, W., Tian, F., Lyu, C., Liu, B., Li, B., Zhang, L., Liu, X., Li, F., Li, D., Gao, X., et al. (2021) · Science Advances · doi:10.1126/sciadv.aba2458 · Cited by 74
Tumor Therapy Strategies Based on Microenvironment‐Specific Responsive Nanomaterials
Zhang, Z., Ding, C., Sun, T., Wang, L., & Chen, C. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300153 · Cited by 78
Dhavale, R. P., Waifalkar, P. P., Sharma, A., Dhavale, R. P., Sahoo, S. C., Kollu, P., Chougale, A. D., Zahn, D. R. T., Salvan, G., Patil, P., et al. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.06.006 · Cited by 72
Two-Photon Luminescent Bone Imaging Using Europium Nanoagents
Surender, E. M., Comby, S., Cavanagh, B., Brennan, O., Lee, T. C., & Gunnlaugsson, T. (2016) · Chem · doi:10.1016/j.chempr.2016.08.011 · Cited by 71
Optically Active Nanomaterials for Bioimaging and Targeted Therapy
Yang, Y., Wang, L., Wan, B., Gu, Y., & Li, X. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00320 · Cited by 73
A redox-activated theranostic nanoagent: toward multi-mode imaging guided chemo-photothermal therapy
Zhang, T., Xu, C.-H., Zhao, W., Gu, Y., Li, X., Xu, J., & Chen, H. (2018) · Chemical Science · doi:10.1039/c8sc02446d · Cited by 69
Molecular imaging: design mechanism and bioapplications
Chen, L., Lyu, Y., Zhang, X., Zheng, L., Li, Q., Ding, D., Chen, F., Li, W., Li, W., Zhang, Y., et al. (2023) · Science China Chemistry · doi:10.1007/s11426-022-1461-3 · Cited by 69
Chen, L., Chen, S., Yuan, Y., Leng, X., Xu, X., Chen, J., Shi, J., Qian, K., Xie, Y., Ding, Q., et al. (2024) · Aggregate · doi:10.1002/agt2.657 · Cited by 70
Metadata
- Authors
- Wong, P. T., & Choi, S. K.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Choi, Seok Ki
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-04-27
- Volume
- 115
- Issue
- 9
- Pages
- 3388-3432
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2053890812
- Cited by
- 507
- References
- 493
- Citations by year
- 2026: 28 · 2025: 35 · 2024: 31 · 2023: 45 · 2022: 35 · 2021: 51 · 2020: 59 · 2019: 64 · 2018: 60 · 2017: 48 · 2016: 40 · 2015: 11
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Office of the Vice President for Research, University of Michigan
- Shanghai Jiao Tong University
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- drug release mechanism, nanomedicine, controlled drug release, anticancer agents, nanocarriers
- MeSH terms
- Theranostic Nanomedicine, Animals, Drug Carriers, Humans, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.